V
V

ViforPharma

交易方向

交易者脈動

技術摘要

小時

財經新聞

EU regulators investigate Vifor Pharma over anti-competitive behaviour

By Foo Yun Chee BRUSSELS, June 20 (Reuters) - EU antitrust regulators are investigating whether Vifor Pharma VIFN.S , which is being acquired by CSL Ltd CSL.AX , disparaged its rival Pharmacosmos in order to hinder competition to its blockbuster iron medicine Ferinject. The European Commission, which opened the probe on Monday, said it has indications of this behaviour going on for many years, which may be in breach of EU rules against companies abusing their dominant position.
V

EU antitrust regulators to probe if Vifor Pharma disparages rival

BRUSSELS, June 20 (Reuters) - EU antitrust regulator on Monday launched an investigation into possible anti-competitive disparagement by Vifor Pharma VIFN.S of its closest rival Pharmacosmos in an apparent attempt to hinder competition against its iron medicine. The European Commission said it has indications of this behaviour going on for many years.
V

European shares fall again with cenbank meetings in focus

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window) * STOXX 600 down for fifth straight session * Spotlight on Fed, ECB, BoE meetings * Vifor Pharma, Ocado nudge STOXX 600 higher * Germany's Ifo slashes GDP growth forecast for 2022 (Updates to close) By Anisha Sircar and Susan Mathew Dec 14 (Reuters) - European shares reversed early gains to end lower for a fifth straight session on Tuesday as technology stocks weighed, while the healthcar
A
H
O
R
U
V
G
E
F
U

Travel stocks push European shares lower on Omicron worries

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window) * Travel, energy stocks lead declines * Markets eye crucial c.bank meetings this week * Vifor Pharma surges on CSL buyout talks (Updates to close) By Anisha Sircar and Shashank Nayar Dec 13 (Reuters) - European shares ended lower on Monday, led by travel and energy stocks over rising Omicron variant risks, while a wave of central bank policy decisions this week kept investor sentiment sub
C
D
M
N
U
V
G
U
E
F
U

European stocks fall as Omicron worries rattle investors

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window) * STOXX 600 gives back a chunk of Wednesdays gains * Apple suppliers hit by report on slowing demand * Vifor Pharma surges on takeover speculation (Updates to close) By Anisha Sircar and Susan Mathew Dec 2 (Reuters) - European shares fell more than 1% on Thursday, as countries ramped up restrictions to curb the spread of the Omicron coronavirus variant, raising worries about hits to a nas
A
H
I
R
V
A
G
E
F
U

細節

熱門資產

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

我們運用 cookies 提供您最佳之網頁使用經驗。更改您的cookie 設定跟詳情。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明